GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (NAS:HQY) » Definitions » Sloan Ratio %

HealthEquity (HealthEquity) Sloan Ratio % : -4.46% (As of Jan. 2024)


View and export this data going back to 2014. Start your Free Trial

What is HealthEquity Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

HealthEquity's Sloan Ratio for the quarter that ended in Jan. 2024 was -4.46%.

As of Jan. 2024, HealthEquity has a Sloan Ratio of -4.46%, indicating the company is in the safe zone and there is no funny business with accruals.


HealthEquity Sloan Ratio % Historical Data

The historical data trend for HealthEquity's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthEquity Sloan Ratio % Chart

HealthEquity Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.31 -2.80 14.61 -1.87 -4.46

HealthEquity Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.87 -4.27 -5.09 -4.75 -4.46

Competitive Comparison of HealthEquity's Sloan Ratio %

For the Health Information Services subindustry, HealthEquity's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where HealthEquity's Sloan Ratio % falls into.



HealthEquity Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

HealthEquity's Sloan Ratio for the fiscal year that ended in Jan. 2024 is calculated as

Sloan Ratio=(Net Income (A: Jan. 2024 )-Cash Flow from Operations (A: Jan. 2024 )
-Cash Flow from Investing (A: Jan. 2024 ))/Total Assets (A: Jan. 2024 )
=(55.712-242.826
--46.074)/3163.79
=-4.46%

HealthEquity's Sloan Ratio for the quarter that ended in Jan. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Jan. 2024 )
=(55.712-242.826
--46.074)/3163.79
=-4.46%

HealthEquity's Net Income for the trailing twelve months (TTM) ended in Jan. 2024 was 4.094 (Apr. 2023 ) + 10.581 (Jul. 2023 ) + 14.673 (Oct. 2023 ) + 26.364 (Jan. 2024 ) = $55.7 Mil.
HealthEquity's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jan. 2024 was 31.538 (Apr. 2023 ) + 77.107 (Jul. 2023 ) + 57.108 (Oct. 2023 ) + 77.073 (Jan. 2024 ) = $242.8 Mil.
HealthEquity's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jan. 2024 was -9.135 (Apr. 2023 ) + -10.249 (Jul. 2023 ) + -15.42 (Oct. 2023 ) + -11.27 (Jan. 2024 ) = $-46.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HealthEquity  (NAS:HQY) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Jan. 2024, HealthEquity has a Sloan Ratio of -4.46%, indicating the company is in the safe zone and there is no funny business with accruals.


HealthEquity Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of HealthEquity's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


HealthEquity (HealthEquity) Business Description

Traded in Other Exchanges
Address
15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. Its technology allows customers to see their tax-advantaged healthcare savings, compare treatment options and pricing, pay healthcare bills, receive benefit information, and earn wellness incentives. The firm primarily partners with health plans and employers and serves as the custodian of its customers' health savings accounts (HSAs). HealthEquity also engages in reimbursement arrangements and offers healthcare incentives to its members. In addition, the company provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Executives
Delano Ladd officer: Executive VP, GC & Corp. Secy. 15W. SCENIC POINTE DR., SUITE 100, DRAPER UT 84020
Ian Sacks director TOWERBROOK CAP., PARK AVENUE TOWER, 65 E 55TH ST., 27TH FLOOR, NEW YORK NY 10022
Elimelech Rosner officer: EVP, Chief Technology Officer 5196 BELMORE COURT, SUWANEE GA 30024
Stephen Neeleman director, officer: Founder and Vice Chairman 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Tyson D. Murdock officer: EVP & CFO 2275 S. 2200 E., SALT LAKE CITY UT 84109
Jon Kessler director, officer: President and CEO 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Frank Corvino director GREENWICH HOSPITAL, 5 PERRYRIDGE ROAD, GREENWICH CT 06830
Larry L Trittschuh officer: EVP Chief Security Officer 1051 RUNNYMEDE ROAD, OAKWOOD OH 45419
James M Lucania officer: EVP & CFO 101 WOLF DRIVE, THOROFARE NJ 08086
Gayle Furgurson Wellborn director 123 TORRENCE CHAPEL ROAD, MOORESVILLE NC 28117
Debra Charlotte Mccowan director 1436 CABRILLO AVENUE, BURLINGAME CA 94010
Paul Black director 400 WOOD ROAD, BRAINTREE MA 02184
Edward Bloomberg officer: Chief Operating Officer 13207 WINDSOR STREET, LEAWOOD KS 66209
Rajesh Natarajan director 7500 DALLAS PARKWAY, SUITE 700, PLANO TX 75024
Evelyn S Dilsaver director C/O LONGS DRUG STORES CORPORATION, 141 NORTH CIVIC DRIVE, WALNUT CREEK CA 94596